Liquid Biopsy Market.pdf

marketresearchengine.com
Liquid Biopsy Market Size By
Application (Non-Cancer Applications,
Cancer Applications), By End User
(Academic and Research Centers,
Hospitals and Physician Laboratories,
Reference Laboratories, Other End
Users), By Clinical Application (Early
Cancer Screening, Recurrence
Monitoring, Treatment Monitoring,
Therapy Selection), By Product and
Service (Instruments, Services, Assay
Kits), By Circulating Biomarker
(Extracellular Vesicles, Circulating
Tumor Cells, Circulating Tumor Dna,
Cell-Free Dna, Other Circulating
Biomarkers), By Technology (Single
Gene Analysis Using Pcr Microarrays,
Multi-Gene-Parallel Analysis Using
Ngs), By Region (North America,
Europe, Asia-Pacific, Rest of the
Liquid Biopsy Market Size, Share, Analysis Report | Marketresearch about:reader?url=https%3A%2F%2Fwww.marketresearchengine.com%...
1 of 19 12/07/2022, 21:22

World), Market Analysis Report,
Forecast 2022-2027
19-24 minutes
Liquid Biopsy Market Size By Application (Non-Cancer
Applications, Cancer Applications), By End User (Academic and
Research Centers, Hospitals and Physician Laboratories,
Reference Laboratories, Other End Users), By Clinical Application
(Early Cancer Screening, Recurrence Monitoring, Treatment
Monitoring, Therapy Selection), By Product and Service
(Instruments, Services, Assay Kits), By Circulating Biomarker
(Extracellular Vesicles, Circulating Tumor Cells, Circulating Tumor
Dna, Cell-Free Dna, Other Circulating Biomarkers), By Technology
(Single Gene Analysis Using Pcr Microarrays, Multi-Gene-Parallel
Analysis Using Ngs), By Region (North America, Europe, Asia-
Pacific, Rest of the World), Market Analysis Report, Forecast
2022-2027
Liquid biopsy is a complicated cancer diagnostic assay
administered using biofluids like blood, CSF, plasma and urine for
cancer detection. Liquid biopsy test is often wont to detect cancer
in early stages.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
2 of 19 12/07/2022, 21:22

Infopedia: Access Our All Reports Online at Affordable Price
CLICK HERE
MARKET SNAPSHOT & REPORT DESCRIPTION TABLE OF
CONTENT MARKET SEGMENTATION
MARKET SNAPSHOT
Major Players
• Mdxhealth SA
• Genomic Health Inc
• Raindance Technologies Inc
• Thermo Fisher Scientific Inc
• Illumina Inc
Study period:
Fastest Growing Market:
Base Year:
Largest Market:
REPORT DESCRIPTION
A liquid biopsy is fast ahead traction as a supplement or alternate
to doing a tissue biopsy for applications in procreative health,
cancer, and transplant medicine. The liquid biopsy techniques
agree the physicians to comprehend the critical nature of the
3 of 19 12/07/2022, 21:22

disease after the finding and screening procedure. The main
biomarker kinds used in liquid biopsy contain circulating cell-free
nucleic acids. Extracellular vesicles are a varied class of lipid-
bound elements shed by any cell in the body in pathological and
physiological conditions. Microarray technology has been widely
used in cancer research for more than a period. Droplet Digital
PCR agrees for the detection of target sequences which are
contemporary in the very low background against other sequences
present at high concentrations. Proteomics platforms include Mass
Spectrometry and biochips. Deficiency of consensus on Standard
Operating Measures and poor compensation structures are some
of the main factors hindering the global liquid biopsy market. The
compensation and treatment monitoring for liquid biopsy is limited,
and it is achieved in a few laboratories. The poor reimbursement
system is a important restraint which restricts the individuals to go
for cancer detection tests and affects cancer biomarkers market
negatively.
The global Liquid Biopsy market report provides geographic
analysis covering regions, such as North America, Europe, Asia-
Pacific, and Rest of the World. The Liquid Biopsy market for each
region is further segmented for major countries including the U.S.,
Canada, Germany, the U.K., France, Italy, China, India, Japan,
Brazil, South Africa, and others.
Competitive Rivalry
Mdxhealth SA, Genomic Health, Inc., Raindance Technologies,
Inc, Thermo Fisher Scientific Inc., Illumina, Inc., Biocept, Inc,
Qiagen N.V., Roche Diagnostics, Bio-Rad Laboratories, Inc.,
Myriad Genetics, Inc, and others are among the major players in
the global Liquid Biopsy market. The companies are involved in
4 of 19 12/07/2022, 21:22

several growth and expansion strategies to gain a competitive
advantage. Industry participants also follow value chain integration
with business operations in multiple stages of the value chain.
The Liquid Biopsy Market has been segmented as below:
Liquid Biopsy Market, By Application
• Non-Cancer Applications
• Cancer Applications
Liquid Biopsy Market, By End User
• Academic and Research Centers
• Hospitals and Physician Laboratories
• Reference Laboratories
• Other End Users
Liquid Biopsy Market, By Clinical Application
• Early Cancer Screening
• Recurrence Monitoring
• Treatment Monitoring
• Therapy Selection
Liquid Biopsy Market, By Product and Service
• Instruments
• Services
• Assay Kits
Liquid Biopsy Market, By Circulating Biomarker
• Extracellular Vesicles
5 of 19 12/07/2022, 21:22

• Circulating Tumor Cells
• Circulating Tumor Dna
• Cell-Free Dna
• Other Circulating Biomarkers
Liquid Biopsy Market, By Technology
• Single Gene Analysis Using Pcr Microarrays
• Multi-Gene-Parallel Analysis Using Ngs
Liquid Biopsy Market, By Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
Liquid Biopsy Market, By Company
• Mdxhealth SA
• Genomic Health, Inc.
• Raindance Technologies, Inc
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Biocept, Inc
• Qiagen N.V.
• Roche Diagnostics
• Bio-Rad Laboratories, Inc.
6 of 19 12/07/2022, 21:22

• Myriad Genetics, Inc
• Menarini-Silicon Biosystems
• Trovagene, Inc.
• Guardant Health, Inc.
The report covers:
• Global Liquid Biopsy market sizes from 2018 to 2027, along with
CAGR for 2022-2027
• Market size comparison for 2020 vs 2027, with actual data for
2021, estimates for 2022 and forecast from 2022 to 2027
• Global Liquid Biopsy market trends, covering comprehensive
range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material
suppliers to the downstream buyer in the global Liquid Biopsy
market
• Major market opportunities and challenges in forecast timeframe to
be focused
• Competitive landscape with analysis on competition pattern,
portfolio comparisons, development trends and strategic
management
• Comprehensive company profiles of the key industry players
Report Scope:
The global Liquid Biopsy market report scope includes detailed
study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market
dynamics. The scope also covers competitive overview providing
7 of 19 12/07/2022, 21:22

company market shares along with company profiles for major
revenue contributing companies.
The report scope includes detailed competitive outlook covering
market shares and profiles key participants in the global Liquid
Biopsy market share. Major industry players with significant
revenue share include Mdxhealth SA, Genomic Health, Inc.,
Raindance Technologies, Inc, Thermo Fisher Scientific Inc.,
Illumina, Inc., Biocept, Inc, Qiagen N.V., Roche Diagnostics, Bio-
Rad Laboratories, Inc., Myriad Genetics, Inc, and others.
Reasons to Buy this Report:
• Gain detailed insights on the Liquid Biopsy industry trends
• Find complete analysis on the market status
• Identify the Liquid Biopsy market opportunities and growth
segments
• Analyse competitive dynamics by evaluating business segments &
product portfolios
• Facilitate strategy planning and industry dynamics to enhance
decision making
Some of the recent developments in Liquid Biopsy Market are
as follows:
Mdxhealth SA
• 10-2019: MDxHealth is a multinational healthcare company which
offers actionable molecular diagnostic information to personalize
the diagnosis and treatment of cancer.
• 27-2018: MDxHealth SA declared the publication of positive data
demonstrating the value of the SelectMDx liquid biopsy test for
8 of 19 12/07/2022, 21:22

Prostate Cancer in guiding patient management for men being
considered for multiparametric MRI and the clinical utility in guiding
biopsy decisions in real-world clinical practice.
Genomic Health, Inc.
• 09-2014: Genomic Health, Inc. declared positive results from its
first two feasibility studies assessing multiple technologies,
including next-generation sequencing, for their ability to detect and
characterize the presence of bladder cancer DNA in urine and
breast cancer DNA in blood.
• 11-2016: Genomic Health, Inc. declared plans to launch its first
liquid biopsy test.
Customization
Customized report as per the requirement can be offered with
appropriate recommendations.
Below are our New Reports :-
Connected Drug Delivery Devices Market
Drug Discovery Services Market
Herbal Bitters Market
3D Cell Culture Market
Acetylspiramycin (CAS 24916-51-6) Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
9 of 19 12/07/2022, 21:22

2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. Liquid Biopsy Market, By Application
5.1 Introduction
5.2 Non-Cancer Applications
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Cancer Applications
6. Liquid Biopsy Market, By End User
6.1 Introduction
10 of 19 12/07/2022, 21:22

6.2 Academic and Research Centers
6.3 Hospitals and Physician Laboratories
6.4 Reference Laboratories
6.5 Other End Users
7. Liquid Biopsy Market, By Clinical Application
7.1 Introduction
7.2 Early Cancer Screening
7.3 Recurrence Monitoring
7.4 Treatment Monitoring
7.5 Therapy Selection
8. Liquid Biopsy Market, By Product and Service
8.1 Introduction
8.2 Instruments
11 of 19 12/07/2022, 21:22

8.3 Services
8.4 Assay Kits
9. Liquid Biopsy Market, By Circulating Biomarker
9.1 Introduction
9.2 Extracellular Vesicles
9.3 Circulating Tumor Cells
9.4 Circulating Tumor Dna
9.5 Cell-Free Dna
9.6 Other Circulating Biomarkers
10. Liquid Biopsy Market, By Technology
10.1 Introduction
10.2 Single Gene Analysis Using Pcr Microarrays
12 of 19 12/07/2022, 21:22

10.3 Multi-Gene-Parallel Analysis Using Ngs
11. Liquid Biopsy Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 North America Liquid Biopsy, By Application
11.2.2 North America Liquid Biopsy, By End User
11.2.3 North America Liquid Biopsy, By Clinical Application
11.2.4 North America Liquid Biopsy, By Product and Service
11.2.5 North America Liquid Biopsy, By Circulating Biomarker
11.2.6 North America Liquid Biopsy, By Technology
11.3 Europe
11.3.1 Europe Liquid Biopsy, By Application
11.3.2 Europe Liquid Biopsy, By End User
11.3.3 Europe Liquid Biopsy, By Clinical Application
11.3.4 Europe Liquid Biopsy, By Product and Service
11.3.5 Europe Liquid Biopsy, By Circulating Biomarker
11.3.6 Europe Liquid Biopsy, By Technology
11.4 Asia-Pacific
11.4.1 Asia-Pacific Liquid Biopsy, By Application
11.4.2 Asia-Pacific Liquid Biopsy, By End User
11.4.3 Asia-Pacific Liquid Biopsy, By Clinical Application
11.4.4 Asia-Pacific Liquid Biopsy, By Product and Service
11.4.5 Asia-Pacific Liquid Biopsy, By Circulating Biomarker
11.4.6 Asia-Pacific Liquid Biopsy, By Technology
11.5 Rest of the World
11.5.1 Rest of the World Liquid Biopsy, By Application
13 of 19 12/07/2022, 21:22

11.5.2 Rest of the World Liquid Biopsy, By End User
11.5.3 Rest of the World Liquid Biopsy, By Clinical Application
11.5.4 Rest of the World Liquid Biopsy, By Product and
Service
11.5.5 Rest of the World Liquid Biopsy, By Circulating
Biomarker
11.5.6 Rest of the World Liquid Biopsy, By Technology
12. Competitive Insights
12.1 Key Insights
12.2 Company Market Share Analysis
12.3 Strategic Outlook
12.3.1 Mergers & Acquisitions
12.3.2 New Product Development
12.3.3 Portfolio/Production Capacity Expansions
12.3.4 Joint Ventures, Collaborations, Partnerships &
Agreements
12.3.5 Others
13. Company Profiles
13.1 Mdxhealth SA
13.1.1 Company Overview
13.1.2 Product/Service Landscape
13.1.3 Financial Overview
13.1.4 Recent Developments
13.2 Genomic Health, Inc.
13.3 Raindance Technologies, Inc
14 of 19 12/07/2022, 21:22

13.4 Thermo Fisher Scientific Inc.
13.5 Illumina, Inc.
13.6 Biocept, Inc
13.7 Qiagen N.V.
13.8 Roche Diagnostics
13.9 Bio-Rad Laboratories, Inc.
15 of 19 12/07/2022, 21:22

13.10 Myriad Genetics, Inc
13.11 Menarini-Silicon Biosystems
13.12 Trovagene, Inc.
13.13 Guardant Health, Inc
The Liquid Biopsy Market has been segmented as below:
Liquid Biopsy Market, By Application
• Non-Cancer Applications
• Cancer Applications
16 of 19 12/07/2022, 21:22

Liquid Biopsy Market, By End User
• Academic and Research Centers
• Hospitals and Physician Laboratories
• Reference Laboratories
• Other End Users
Liquid Biopsy Market, By Clinical Application
• Early Cancer Screening
• Recurrence Monitoring
• Treatment Monitoring
• Therapy Selection
Liquid Biopsy Market, By Product and Service
• Instruments
• Services
• Assay Kits
Liquid Biopsy Market, By Circulating Biomarker
• Extracellular Vesicles
• Circulating Tumor Cells
• Circulating Tumor Dna
• Cell-Free Dna
• Other Circulating Biomarkers
Liquid Biopsy Market, By Technology
• Single Gene Analysis Using Pcr Microarrays
17 of 19 12/07/2022, 21:22

• Multi-Gene-Parallel Analysis Using Ngs
Liquid Biopsy Market, By Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
Liquid Biopsy Market, By Company
• Mdxhealth SA
• Genomic Health, Inc.
• Raindance Technologies, Inc
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Biocept, Inc
• Qiagen N.V.
• Roche Diagnostics
• Bio-Rad Laboratories, Inc.
• Myriad Genetics, Inc
• Menarini-Silicon Biosystems
• Trovagene, Inc.
• Guardant Health, Inc.
Got a question? We've got answers. If you have some other
questions, see our support center.
The segment included in the Liquid Biopsy market is Application,
18 of 19 12/07/2022, 21:22

End User, Clinical Application, Product and Service, Circulating
Biomarker, Technology, Company and region.
Some key players operating in the Liquid Biopsy market include
Mdxhealth SA, Genomic Health, Inc., Raindance Technologies,
Inc, Thermo Fisher Scientific Inc., Illumina, Inc., Biocept, Inc,
Qiagen N.V., Roche Diagnostics, Bio-Rad Laboratories, Inc
We can offer several formats of the market research reports
including, • PDF • PPT • Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE
19 of 19 12/07/2022, 21:22

Liquid Biopsy Market.pdf

Recommended

Recommended

More Related Content

More from danishsmith01

More from danishsmith01 (20)

Liquid Biopsy Market.pdf